No rapid e f f e c t s of grcwth hormone (CHI in isolated hman c e l l s have been m a s r e d until nw. hman monwclear c e l l s were used to exmine t k effects of h a n GH (KH) on the activity of the pyruvate drl~ydroq?nase (POH) c q l e x . Cells (Bx106/ml) were incubated a t 37' C for v a r i w s tines in the presence of lo-'# tCH or porcine insulin. PMI activity was determined in sonicated c e l l s by masuring IUCO2 liberation fran 1-"C-pyruvate.
exmine t k effects of h a n GH (KH) on the activity of the pyruvate drl~ydroq?nase (POH) c q l e x . Cells (Bx106/ml) were incubated a t 37' C for v a r i w s tines in the presence of lo-'# tCH or porcine insulin. PMI activity was determined in sonicated c e l l s by masuring IUCO2 liberation fran 1-"C-pyruvate.
Increase in basal PDH ectivity was l iwnr a s a function of t i m (up t o 20 m i d , of pyruvate concentration (up t o 0.25 rrM) and of proteins (up t o 4x10' cells). Ten subjects, aq?d 5 t o 40 years, were studied. Basal POH activity represented 24 % of the total PDH ectivity (20.54 + 1.19 pml/ min/lo6 cells). Treatment of nunauclear c e l l s by tCH led t o an increase in base1 PDH activity which was maximal (53 5 7% above control value) a t 15 min. Later on, activation progressively decreased and was no longer detectable a t 30 min. Total PMI activity ( m a s r e d i n tlu? presence of 0.5 RM C&l2 end 20 rrM MgC12) was unaffected by tCH treatmnt. Incubation of c e l l s with insulin also increased basal PDH activity (65 + 9% above control value) a t 15 min, withwt changing' total PMI activity. In conclusion, hTH a s well a s insulin,is able t o stirmlate PMI activity of bman monoruclear cells. This hormonal effect allcws the rapid evaluation of the cellular responsiveness t o GH in v a r i w s pathophysiologic situations. No effect of C H on PDH ectivity was observed in c e l l s prepared fran two Leron drarfs. The prognostic value of 15N-(stable isotope nitrogen)-retentlon (~nass-spectrometry) and serum levels of fragments of type I collagen (bone and Interstitial fibrlls) and type 111 procollagen (interstitial fibrils) ( both by RIA) was studied in 20 hCH deficient children (median age: 10 ys). Patients showing good responses to hGH-therapy (increases above 1 SI)S of height for chronological age a f t e r 1 year of treatment) had higher m(!:in collager~ levels during treatment (Type 1: 214 + 14 vs. 200 + 14 ng:mi; Type 111: 43.3 f 13.7 vs. 39.5 f 8.0 ngiml) than those with smaller responses. The median increase after 3 days of hGH (21U:m2/die) was higher in those with better responses (Type 1: 22 vs. 10 ngl mi; Type 111: 13.5 vs. 7.2 ng~ml). Cumulative renal 15N-excretion decreased from pretreatment median v:~lucs of 0.91 to 0.54 mg/i5N!kg. However. 15N-rctention (in %) was identical for good and poor hGH responders (-1.1 91). Shortterm administral.ion ( 3 x 21U'm2) in patients wit11 Turner's Syndrome (n=5) showed no median change of type 111 collagen (1.i npl'ml) and 16N retention (9.2%). Therefore, longterm hGHtreatment with such doses in Turner patients are not likely to induce optimal growth responses. Furthermore. these results suggest studies of both 15N-retention test, a s well a s type I and type Ill collagen serum levels to predict the response before initlation of longterm hGH-treatment. J.J. van der Werff t e n Bosch and A. Bot*.
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GROWTH IIORMONE IIASTENS BONE MATUPATION DURING 'PUBERTY' IN HYPOPITUITARY BOYS.
S k e l e t a l maturation r a t e (SMR) during spontaneous o r induced (pseudo-) puberty was studied i n boys wit11 hypopituitary dwarfisn~, 30 t r e a t e d with hGII, 26 without. Bone age (BA, Greul i c h L Pyle) was estimated a t the time when pubertal s i g n s were f i r s t noted o r when androgen s u b s t i t u t i o n was begun. When f i n a l i~e i g h t was reached pubertal growth was considered t o have ended and B A assumed t o be maximal (19 y). SMR (mean 0.91, SEM 0.058) was negatively c o r r e l a t e d with i n i t i a l B A (mean 11.2, SEH 0.37) i n boys without hGH; i n only 4/26 SMR exceeded 1 yly. For boys with hGli there was no c o r r e l a t i o n between SMR (mean 1.54, SEM 0.070) and i n i t i a l BA (mean 11.5, SEM 0.26); i n 26/30 SMR exceeded 1 yly. Conclusions: androgen-induced s k e l e t a l maturation occurs f a s t e r i n presence of hGll than i n i t s absence: t h i s explains e a r l i e r f i n d i n g of s i m i l a r f i n a l h e i g l~t s of hypopituitary boys with and without hGH-treatment. Hence hGII-treatment must aim a t g r e a t e s t possible height before puberty.
K. Damm J s r q e n s e n * , S . J e n s e n * ( I n t r o d . b y N.E. S k a k k e b a k ) .
D e p a r t m e n t s o f P h a r m a c o l o g i c a l a n d C l i n i c a l R e s e a r c h , N o r d i s k G e n t o f t e A/S. EFFECT OF GROWTil IIORMONE TREATMENT ON ULTI-MATE WEIGHT AND LENGTH OF TURNER MICE. T u r n e r m i c e ( x o ) a n d x x m i c e w i t h t h e same g e n e t i c b a c k g r o u n d w e r e t r e a t e d f o r a 6-month p e r i o d w i t h d a i l y s u b c u t a n e o u s d o s e s o f 0 . 5 I U ~o r d i t r o p i n~ o r p l a c e b o , s t a r t i n g a t t h e a g e o f 5 w e e k s t o 5 m o n t h s . T h e T u r n e r m i c e w h i c h w e r e t r e a t e d w i t h ~o r d i t r o p i n~ r e a c h e d a s i g n i f i c a n t l y h i g h e r u l t i m a t e b o d y w e i g h t ( a b o u t 38g)
a n d u l t i m a t e l e n g t h ( n o s e t o t i p o f t h e t a i l -a b o u t 2 1 . 5 c m ) c o m p a r e d t o t h e p l a c e b o -t r e a t e d T u r n e r m i c e ( a b o u t 2 8 9 a n d 1 9 c m ) . T h e b o d y w e i g h t r e m a i n e d c o n s t a n t a f t e r c e s s a t i o n o f t r e a t m e n t . T h e r e w a s n o c o r r e l a t i o n b e t w e e n a g e a t t h e s t a r t o f t r e a t m e n t a n d u l t i m a t e w e i g h t o r l e n g t h . Upon s a c r i f i c e i t w a s f o u n d t h a t t h e f e m o r a l a n d t i b i a b o n e s f r o m t h e ~o r d i t r o~i n~-t r e a t e d T u r n e r m i c e w e r e s i g n i l i c a n t l y l o n g e r c o m p a r e d t o p l a c e b o m i c e . T h e u lt i m a t c w e i g h t a n d l e n g t h o f t h e ~o r d i t r o~i n~-t r e a t e d x x m i c e , a s w e l l a s t h e l e n g t h o f t h e i r b o n e s , w e r e n o t s i g n i f i c a n t l y d i f f e r e n t f r o m t h e c o m p a r a b l e p a r a m e t e r s i n p l a c e b o -t r e a t e d x x m i c e . B o t h x o a n d x x m i c e r e a c h e d t h e i r u l t i m a t e ; ( e i g h t s i g n i f i c a n t l y f a s t e r when t h e y w e r e t r e a t e d w i t h ~o r d i t r o p i n~ c o m p a r e d t o p l a c e b o ( m e a n s : 2 2 . 1 a n d 1 9 . 7 w e e k s r e s p e c t i v e l y a f t e r s t a r t o f d o s i n g ) .
R.
Sandhu VJe have compared levels of serum growth hormone (CHI in children with growth d i s o r d e r s using t h e Nb2 node lymphoma (Nb2BA) bioassay a n d immunoradiometric (IRMA) a s s a y .
Seven children (2 tall, 2 s h o r t normal, 3 CH insufficient) showed identical s e c r e t o r y p a t t e r n s b y time s e r i e s analysis b u t Nb2BA CH was nearly twice a s high a s IRMA CtI. T h e r e was a high correlation between IRMA a n d Nb2BA b u t daytime samples showed a b e t t e r correlation than those obtained a t night.
It is s u g g e s t e d t h a t some residual stimulation of Nb2BA b y prolactin o c c u r r e d in t h e serum despite t h e addition of a 1:1000 dilution of prolactin monoclonal antibody.
Four boys with delayed p u b e r t y were also studied. Although t h e CH profiles were identical, CH concentrations were lower in Nb2BA than IRMA. All 4 boys g r e w on low dose oxandrolone (1.25-2.5mglday) a n d analysis of CIi profiles b y t h e two methods showed a n increase in t h e ratio of Nb2BA:IRMA CH to 1.5:l. T h e s e data s u g g e s t t h a t differences between bioactivity a n d immunoreactivity may b e relevant to t h e measurement of CH concentrations in patients with delayed p u b e r t y .
